[{"Assets_0_Q1_USD":129285000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":3894000000.0,"NetIncomeLossConverted_1_Q1_USD":-766000000.0,"RevenuesConverted_1_Q1_USD":10781000000.0,"StockholdersEquity_0_Q1_USD":49911000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":2258000000.0,"StockholdersEquityConverted_0_Q1_USD":49977000000.0,"EarningsPerShareBasic_1_Q1_USD":-0.34,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":2258000000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.34,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.45,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20200507"}]